Impact of venous leg ulceration on health-related quality of life: A synthesis of data from randomized controlled trials compared to population norms

被引:19
|
作者
Jull, Andrew [1 ,2 ]
Muchoney, Sara [2 ]
Parag, Varsha [2 ]
Wadham, Angela [2 ]
Bullen, Chris [2 ]
Waters, Jill [3 ]
机构
[1] Univ Auckland, Sch Nursing, Private Bag 92019, Auckland 1023, New Zealand
[2] Univ Auckland, Natl Inst Hlth Innovat, Auckland, New Zealand
[3] Auckland Dist Hlth Board, Auckland, New Zealand
关键词
STANDARD CARE; NEW-ZEALAND; ULCERS; INSTRUMENTS; VALIDITY;
D O I
10.1111/wrr.12636
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Venous insufficiency is the most common cause of leg ulceration, but the impact of venous leg ulceration on health-related quality of life has not been adequately assessed. This study compared data from randomized controlled trials to population norms obtained from a large national population survey. We combined the baseline Short Form-36 (SF-36) version 1 data from two New Zealand randomized controlled trials that recruited participants with VLU and compared the pooled data to the population scores obtained from the New Zealand Health Survey using general linear regression to adjust for age, sex, and ethnicity differences between the cohorts. Baseline SF-36 scores obtained from 618 trial participants were compared to the SF-36 scores obtained from the 12,529 participants in the New Zealand Health Survey. Participants with VLU had significantly lower crude SF-36 scores across all eight SF-36 domains, but there was interaction between age and group. Adjusted mean differences for participants aged 65 years or younger were - 25.8, -32.1, -21.2, -9.6, -7.6, -23.9, -21.5, and -9.3, respectively, for Physical Functioning, Role Physical, Bodily Pain, General Health, Vitality, Social Functioning, Role Emotional, and Mental Health whereas the adjusted mean differences for older participants were -15.7, -23.8, -13.8, -0.3 (nonsignificant), - 4.6, -15.3, -21.2, and -6.6. This study is the first to compare a VLU population to norms from a general population survey and the first to show VLU interacts with age creating stronger impact in younger patients compared their age cohort. Younger patients may have need of more pastoral care as a consequence.
引用
收藏
页码:206 / 212
页数:7
相关论文
共 50 条
  • [31] Health-related quality of life in Korean lymphoma survivors compared with the general population
    Kim, Soo Hyun
    Kim, Im-Ryung
    Kim, So Hee
    Lee, Suyeon
    Ok, Onam
    Kim, Won Seog
    Suh, Cheolwon
    Lee, Moon Hee
    ANNALS OF HEMATOLOGY, 2014, 93 (09) : 1531 - 1540
  • [32] Impact of biologics on health-related quality of life in patients with Ankylosing spondylitis: A systematic review and meta-analysis of randomized controlled trials
    Ho, Anh
    Younis, Ibrahim
    Le, Quang A.
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2022, 54
  • [33] Improved health-related quality of life with effective disease-modifying antirheumatic drugs: Evidence from randomized controlled trials
    Strand, Vibeke
    Singh, Jasvinder A.
    AMERICAN JOURNAL OF MANAGED CARE, 2008, 14 (04): : 239 - 253
  • [34] Functional Ability and Health-Related Quality of Life in Randomized Controlled Trials of Tocilizumab in Patients With Juvenile Idiopathic Arthritis
    Brunner, Hermine I.
    Chen, Chen
    Bovis, Francesca
    De Benedetti, Fabrizio
    Espada, Graciela
    Joos, Rik
    Akikusa, Jonathan
    Chaitow, Jeffrey
    Boteanu, Alina Lucica
    Kimura, Yukiko
    Rietschel, Christoph
    Siri, Daniel
    Smolewska, Elzbieta
    Schmeling, Heinrike
    Brown, Diane E.
    Martini, Alberto
    Lovell, Daniel J.
    Huang, Bin
    Ruperto, Nicolino
    ARTHRITIS CARE & RESEARCH, 2021, 73 (09) : 1264 - 1274
  • [35] Health-related quality of life in two randomized controlled trials of phentermine/topiramate for obesity: What mediates improvement?
    Ronette L. Kolotkin
    Kishore M. Gadde
    Craig A. Peterson
    Ross D. Crosby
    Quality of Life Research, 2016, 25 : 1237 - 1244
  • [36] A structured review of randomized controlled trials of weight loss showed little improvement in health-related quality of life
    Maciejewski, ML
    Patrick, DL
    Williamson, DF
    JOURNAL OF CLINICAL EPIDEMIOLOGY, 2005, 58 (06) : 568 - 578
  • [37] Health-related quality of life in two randomized controlled trials of phentermine/topiramate for obesity: What mediates improvement?
    Kolotkin, Ronette L.
    Gadde, Kishore M.
    Peterson, Craig A.
    Crosby, Ross D.
    QUALITY OF LIFE RESEARCH, 2016, 25 (05) : 1237 - 1244
  • [38] Impact of diabetes on health-related quality of life in a population study in Japan
    Saito, Isao
    Inami, Fujiko
    Ikebe, Toshiko
    Moriwaki, Chinatsu
    Tsubakimoto, Akiko
    Yonemasu, Kunio
    Ozawa, Hideki
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2006, 73 (01) : 51 - 57
  • [39] IMPACT OF HEALTHCARE ACCESS ON HEALTH-RELATED QUALITY OF LIFE IN THE TUNISIAN POPULATION
    Aziz, B.
    Drira, C.
    Felfel, H.
    Kooli, A.
    Khrouf, Razgallah M.
    VALUE IN HEALTH, 2020, 23 : S684 - S684
  • [40] IMPACT OF CHRONIC CONDITIONS ON HEALTH-RELATED QUALITY OF LIFE IN TUNISIAN POPULATION
    Jebabli, M.
    Felfel, H.
    Drira, C.
    Kooli, A.
    Khrouf, Razgallah M.
    VALUE IN HEALTH, 2020, 23 : S617 - S617